{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:30:20Z","timestamp":1758040220378,"version":"3.44.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,10]]},"DOI":"10.7759\/cureus.92027","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:58:16Z","timestamp":1757573896000},"source":"Crossref","is-referenced-by-count":0,"title":["Regional Disparities in Multiple Sclerosis Care in Poland: Epidemiology, Workforce Challenges, and Continuity of Care"],"prefix":"10.7759","author":[{"given":"Katarzyna","family":"Bruka\u0142o","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition","volume":"26","author":"Walton C","year":"2020","unstructured":"Walton C, King R, Rechtman L, et al.. Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition. Mult Scler. 2020, 26:1816-21. 10.1177\/1352458520970841","journal-title":"Mult Scler"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000768","article-title":"Atlas of Multiple Sclerosis 2013: a growing global problem with widespread inequity","volume":"83","author":"Browne P","year":"2014","unstructured":"Browne P, Chandraratna D, Angood C, Tremlett H, Baker C, Taylor BV, Thompson AJ. Atlas of Multiple Sclerosis 2013: a growing global problem with widespread inequity. Neurology. 2014, 83:1022-4. 10.1212\/WNL.0000000000000768","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5603\/PJNNS.a2021.0039","article-title":"Neurological symptoms in hospitalised patients with COVID-19 and their association with in-hospital mortality","volume":"55","author":"Wnuk M","year":"2021","unstructured":"Wnuk M, Sawczy\u0144ska K, K\u0119sek T, et al.. Neurological symptoms in hospitalised patients with COVID-19 and their association with in-hospital mortality. Neurol Neurochir Pol. 2021, 55:314-21. 10.5603\/PJNNS.a2021.0039","journal-title":"Neurol Neurochir Pol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517694432","article-title":"New insights into the burden and costs of multiple sclerosis in Europe","volume":"23","author":"Kobelt G","year":"2017","unstructured":"Kobelt G, Thompson A, Berg J, Gannedahl M, Eriksson J. New insights into the burden and costs of multiple sclerosis in Europe. Mult Scler. 2017, 23:1123-36. 10.1177\/1352458517694432","journal-title":"Mult Scler"},{"key":"ref5","article-title":"Aging of the neurology workforce in Europe: a call for coordinated action","volume":"28","author":"Leone MA","year":"2021","unstructured":"Leone MA, Keindl M, Raoof R, et al.. Aging of the neurology workforce in Europe: a call for coordinated action. Eur J Neurol. 2021, 28:2756-65.","journal-title":"Eur J Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-018-0082-z","article-title":"Treatment of multiple sclerosis - success from bench to bedside","volume":"15","author":"Tintore M","year":"2019","unstructured":"Tintore M, Vidal-Jordana A, Sastre-Garriga J. Treatment of multiple sclerosis - success from bench to bedside. Nat Rev Neurol. 2019, 15:53-8. 10.1038\/s41582-018-0082-z","journal-title":"Nat Rev Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005345","article-title":"Comprehensive systematic review summary: disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology","volume":"90","author":"Rae-Grant A","year":"2018","unstructured":"Rae-Grant A, Day GS, Marrie RA, et al.. Comprehensive systematic review summary: disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2018, 90:789-800. 10.1212\/WNL.0000000000005345","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-015-7842-0","article-title":"High incidence and increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (1991-2010)","volume":"262","author":"Kingwell E","year":"2015","unstructured":"Kingwell E, Zhu F, Marrie RA, et al.. High incidence and increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (1991-2010). J Neurol. 2015, 262:2352-63. 10.1007\/s00415-015-7842-0","journal-title":"J Neurol"},{"key":"ref9","article-title":"The US multiple sclerosis workforce: physician supply, distribution, and demography","volume":"5","author":"Tyry T","year":"2015","unstructured":"Tyry T, Salter A, Vollmer T, et al.. The US multiple sclerosis workforce: physician supply, distribution, and demography. Neurol Clin Pract. 2015, 5:143-150.","journal-title":"Neurol Clin Pract"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000622","article-title":"Multiple sclerosis: clinical aspects","volume":"31","author":"Oh J","year":"2018","unstructured":"Oh J, Vidal-Jordana A, Montalban X. Multiple sclerosis: clinical aspects. Curr Opin Neurol. 2018, 31:752-9. 10.1097\/WCO.0000000000000622","journal-title":"Curr Opin Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","year":"2019","unstructured":"Global, regional, and national burden of neurological disorders, 1990-2016. a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019, 18:459-80. 10.1016\/S1474-4422(18)30499-X","journal-title":"Lancet Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30411-9","article-title":"The global burden of neurological disorders: translating evidence into policy","volume":"19","author":"Feigin VL","year":"2020","unstructured":"Feigin VL, Vos T, Nichols E, et al.. The global burden of neurological disorders: translating evidence into policy. Lancet Neurol. 2020, 19:255-65. 10.1016\/S1474-4422(19)30411-9","journal-title":"Lancet Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/13524585231197076","article-title":"Diagnostic delay of multiple sclerosis: prevalence, determinants and consequences","volume":"29","author":"Uher T","year":"2023","unstructured":"Uher T, Adzima A, Srpova B, et al.. Diagnostic delay of multiple sclerosis: prevalence, determinants and consequences. Mult Scler. 2023, 29:1437-51. 10.1177\/13524585231197076","journal-title":"Mult Scler"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-28864-x","article-title":"Multiple sclerosis diagnostic delay and its associated factors in Upper Egyptian patients","volume":"13","author":"Khedr EM","year":"2023","unstructured":"Khedr EM, El Malky I, Hussein HB, Mahmoud DM, Gamea A. Multiple sclerosis diagnostic delay and its associated factors in Upper Egyptian patients. Sci Rep. 2023, 13:2249. 10.1038\/s41598-023-28864-x","journal-title":"Sci Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(24)00038-3","article-title":"Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"23","year":"2024","unstructured":"Global, regional, and national burden of disorders affecting the nervous system, 1990-2021. a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 2024, 23:344-81. 10.1016\/S1474-4422(24)00038-3","journal-title":"Lancet Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/408058-regional-disparities-in-multiple-sclerosis-care-in-poland-epidemiology-workforce-challenges-and-continuity-of-care","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:58:16Z","timestamp":1757573896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/408058-regional-disparities-in-multiple-sclerosis-care-in-poland-epidemiology-workforce-challenges-and-continuity-of-care"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.92027","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,9,10]]}}}